We offer safety-proof patient experiences with effective monitoring, analysis, reporting, and risk mitigation of adverse event signals across the product life cycle. Indegene's pharmacovigilance solution offer a digitally enabled solution to help you reduce your total cost of ownership while ensuring persistent regulatory compliance.

1. Safety

2. Indegene is a global transformation partner to life sciences
organizations
Los Angeles
Toronto
US HQ - NJ
EU & UK
Singapore
China
Japan
Atlanta
India
Primary
Delivery Hub –
E2E
Capabilities
Strategic Partnerships
Mexico
Global Delivery Centers
Global Presence
22 years
of life sciences
expertise
5,500+
Passionate
employees
1,500+ Life
science & medical
experts
15
Offices around
the world
20
Omnichannel hubs
in operation
> 100
Markets served
globally
50+
Therapeutic Areas
$200M
Investment from
Carlyle & Co
© 2023 Indegene. All rights reserved. 2

3. © 2023 Indegene. All rights reserved. 3
We bring together domain, technology and thought leadership to
drive transformation for global pharma
2010 2015 2019
2016 2017
2013
2011 2012 2014 2018 2020 2021 2022
Efficiency Effectiveness Excellence

4. AE, MI, PQC
Monitoring & Intake
Triage,
data entry & QC
Medical Review &
Quality Assurance
Aggregate Reporting &
Safety Documents
Signal &
Risk Management*
Managed services that brings together our people and technology platform NAEM
600+
PV Specialists
>1M
Cases Processed
1000+
Aggregate & Safety Documents
70+
Signals
15+
Therapeutic Areas
20+
Geographies
6+
Product categories.
99.2%
Time compliance
98%
Quality compliance
>45%
Savings
Our breadth of services and experience gained positions us well to serve the needs of our customers
We have a proven model that delivers impact
Consulting services that help organizations leap forward in maturity levels
© 2023 Indegene. All rights reserved. 4
We have an established PV practice that centered around delivering
customer impact

5. © 2023 Indegene. All rights reserved. 5
We understand your priorities and pain points
“Retrospective analysis
showed 20% of ICSRs had
quality gaps”
“ Inspection readiness from
day 1 is key...It is also
important to comply with HA
requirements as and when
they come up..”
“ AE volumes are growing
15%+ YoY…it is important to
keep cost of operations low”
“>40% of the budget in PV is
spent on manual intensive
repeat tasks that can be
automated”
“1 in 3 cases need follow
up- we need a way to intake
AE right first time”
“ Analytics and intelligence
are under-utilized in PV..it
has the potential to reduce
20-35% effort in signal and
AR”
Survey of safety leaders across organizations on top priorities - % respondents
~80%
~75%
Quality &
Compliance
Cost effective
operations
Future proof
solutions
~55%
1
2
3

6. Thank you